Published in J AIDS Clin Res on November 01, 2015
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med (2010) 50.17
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med (2012) 27.84
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med (2012) 20.03
Preexposure prophylaxis for HIV infection among African women. N Engl J Med (2012) 15.28
Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med (2015) 9.20
The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol (2005) 7.30
Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med (2011) 6.79
Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis (2013) 5.40
Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep (2011) 4.85
Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morb Mortal Wkly Rep (2012) 2.95
Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS One (2014) 2.85
How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav (2014) 1.93
Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users. MMWR Morb Mortal Wkly Rep (2013) 1.72
Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Educ Prev (2012) 1.53
Two years of Truvada for pre-exposure prophylaxis utilization in the US. J Int AIDS Soc (2014) 1.20
Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDS (2014) 1.19
Women out loud: how women living with HIV will help the world end AIDS. BJOG (2013) 1.02
Effectiveness of the male latex condom: combined results for three popular condom brands used as controls in randomized clinical trials. Contraception (2004) 0.94
Preexposure Prophylaxis For HIV Prevention: What We Know and What We Still Need to Know for Implementation. Top Antivir Med (2015) 0.89
Racial differences and correlates of potential adoption of preexposure prophylaxis: results of a national survey. J Acquir Immune Defic Syndr (2013) 0.87
Perspectives on HIV prevention among urban black women: a potential role for HIV pre-exposure prophylaxis. AIDS Patient Care STDS (2014) 0.85
Focusing to achieve a world without AIDS. JAMA (2015) 0.83
The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol (2005) 7.30
Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health (2004) 2.66
Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis (2004) 2.66
Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis (2004) 1.94
Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation. PLoS One (2010) 1.46
Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV. AIDS (2016) 1.45
Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis (2010) 1.42
Exploring the use of mobile phone technology for the enhancement of the prevention of mother-to-child transmission of HIV program in Nyanza, Kenya: a qualitative study. BMC Public Health (2013) 1.39
Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection. J Acquir Immune Defic Syndr (2010) 1.37
Retention and attendance of women enrolled in a large prospective study of HIV-1 in the United States. J Womens Health (Larchmt) (2009) 1.33
Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection. Arterioscler Thromb Vasc Biol (2014) 1.32
CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women. J Infect Dis (2003) 1.29
Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. Drug Alcohol Depend (2007) 1.28
Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology (2010) 1.28
HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals. J Immunol (2008) 1.19
Quality of life, psychosocial health, and antiretroviral therapy among HIV-positive women in Zimbabwe. AIDS Care (2009) 1.16
Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Am J Drug Alcohol Abuse (2008) 1.14
Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women. AIDS Patient Care STDS (2009) 1.14
The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. J Infect Dis (2011) 1.13
Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women. AIDS (2013) 1.01
HIV/AIDS knowledge scores and perceptions of risk among African American students attending historically black colleges and universities. Public Health Rep (2011) 1.01
Urinary markers of kidney injury and kidney function decline in HIV-infected women. J Acquir Immune Defic Syndr (2012) 1.01
Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy. Antivir Ther (2011) 1.01
Variations in serum müllerian inhibiting substance between white, black, and Hispanic women. Fertil Steril (2008) 0.99
Perinatal depressive symptoms in HIV-infected versus HIV-uninfected women: a prospective study from preconception to postpartum. J Womens Health (Larchmt) (2011) 0.97
Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity. J Acquir Immune Defic Syndr (2013) 0.96
Taking it one day at a time: African American women aging with HIV and co-morbidities. AIDS Patient Care STDS (2014) 0.95
Sexual serosorting among women with or at risk of HIV infection. AIDS Behav (2011) 0.95
HIV and recent illicit drug use interact to affect verbal memory in women. J Acquir Immune Defic Syndr (2013) 0.95
HIV infection and women's sexual functioning. J Acquir Immune Defic Syndr (2010) 0.94
Increased Fracture Incidence in Middle-Aged HIV-Infected and HIV-Uninfected Women: Updated Results From the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2015) 0.94
Prevalence of abnormalities in vestibular function and balance among HIV-seropositive and HIV-seronegative women and men. PLoS One (2012) 0.93
Correlates of CD4+ and CD8+ lymphocyte counts in high-risk immunodeficiency virus (HIV)-seronegative women enrolled in the women's interagency HIV study (WIHS). Hum Immunol (2007) 0.91
Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy. J Virol (2011) 0.91
Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe. PLoS One (2011) 0.90
Pain, psychological symptoms and prescription drug misuse in HIV: A literature review. J Pain Manag (2012) 0.90
Sexual minority status and violence among HIV infected and at-risk women. J Gen Intern Med (2014) 0.89
HIV-1 decreases the levels of neurotrophins in human lymphocytes. AIDS (2011) 0.88
The association of perceived stress and verbal memory is greater in HIV-infected versus HIV-uninfected women. J Neurovirol (2015) 0.87
Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women. AIDS (2007) 0.85
Preventing tuberculosis among HIV-infected pregnant women in Lesotho: the case for rolling out active case finding and isoniazid preventive therapy. J Acquir Immune Defic Syndr (2014) 0.85
Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus. Am J Obstet Gynecol (2003) 0.85
Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation. Altern Ther Health Med (2008) 0.85
Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women. Clin Infect Dis (2009) 0.83
Impact of menopause on condom use by HIV-seropositive and comparison seronegative women. J Acquir Immune Defic Syndr (2008) 0.82
Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach. AIDS (2013) 0.82
Longitudinal Trends in Sexual Behaviors with Advancing Age and Menopause Among Women With and Without HIV-1 Infection. AIDS Behav (2015) 0.82
Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women. J Acquir Immune Defic Syndr (2014) 0.80
High-grade cervical disease in adolescents with HIV. J Low Genit Tract Dis (2008) 0.79
Unusual five amino acid insert within subtype C HIV-1 envelope contributes to dual-tropism (X4R5). AIDS (2010) 0.78
Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C. J Acquir Immune Defic Syndr (2016) 0.78
Single-nucleotide polymorphisms in TrkB and risk for depression: findings from the women's interagency HIV study. J Acquir Immune Defic Syndr (2013) 0.78
Psychosocial correlates of gender-based violence among HIV-infected and HIV-uninfected women in three US cities. AIDS Patient Care STDS (2014) 0.77
African American women's perspectives on 'down low/DL' men: implications for HIV prevention. Cult Health Sex (2012) 0.77
Chronic depressive symptoms and Framingham coronary risk in HIV-infected and HIV-uninfected women. AIDS Care (2011) 0.76
Changes in Urinary Biomarkers over 10 Years is Associated with Viral Suppression in a Prospective Cohort of Women Living with HIV. J Acquir Immune Defic Syndr (2016) 0.75
Smoking, HIV, and risk of pregnancy loss. AIDS (2016) 0.75
Life begins at 60: Identifying the social support needs of African American women aging with HIV. J Health Care Poor Underserved (2017) 0.75
Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009. J Acquir Immune Defic Syndr (2016) 0.75
Increased glucose transporter-1 EXPRESSION on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease. AIDS (2016) 0.75
Sexual minority women and depressive symptoms throughout adulthood. Am J Public Health (2014) 0.75
Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women. J Acquir Immune Defic Syndr (2016) 0.75
Perceived and post-traumatic stress are associated with decreased learning, memory, and fluency in HIV-infected women. AIDS (2017) 0.75
Association of a 3' Untranslated Region Polymorphism in PCSK9 with HIV Viral Load and CD4+ Levels in HIV/Hepatitis C Virus Co-Infected Women. AIDS (2017) 0.75
Exosomes from uninfected cells activate transcription of latent HIV-1. J Biol Chem (2017) 0.75